FHA
RETA

First Horizon Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

First Horizon Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-272
Closed -$27.7K – 2540
2023
Q2 		$27.7K Hold
272
– – ﹤0.01% 1144
2023
Q1 		$24.7K Sell
272
-114
-30% -$10.4K ﹤0.01% 1181
2022
Q4 		$14.7K Buy
+386
New +$14.7K ﹤0.01% 1384